Opik Taupiqurrohman
@staba.ac.id
Department of Medical Laboratory Technology
Sekolah Tinggi Analis Bakti Asih
RESEARCH INTERESTS
Biology Applied, Biotechnology, Bioinformatics
4
Scopus Publications
Scopus Publications
- From fermentation to cancer prevention: The anticancer potential of Kombucha
Opik Taupiqurrohman, Lathifah Puji Hastuti, Dina Oktavia, Belal Omar Al-Najjar, Muhammad Yusuf, Yani Suryani, and Shabarni Gaffar
Elsevier BV - Comparison of potential compounds Saussureamine D and Saussureamine e from the plant Saussurea costus falc. as a inhibitor of SARS CoV-2 RNA-dependent RNA-polymerase (RDRP) in silico
Yani Suryani, Opik Taupiqurrohman, Adisty Virakawugi Darniwa, Fauzan Ahsan Hafizhin, Aep Kusnawan, Sarbini, Abdul Wasyik, Gilang Aditya Purba, and Budiman Eko Wibowo
AIP Publishing - Development of Ebola Vaccine Candidate by in Silico from Glikoprotein (GP) Gene of Ebola Zaire Virus
Yani Suryani, Opik Taupiqurrohman, Sri Aryanti, Moh. Nurul Subkhi, and Epa Paujiah
IOP Publishing - Insilico docking studies of daidzeion compounds as selective estrogen receptor modulator (SERMS) breast cancer
Yani Suryani, Opik Taupiqurrohman, Ai Rikani, and Epa Paujiah
EDP Sciences
The aims of this study to analyze the potential of daidzein compounds as selective estrogen receptor modulators (SERMs) compared with 17-β estradiol. SERMs is a compound that can be used as a anticancer of breast cancer. The process of analysis is done computation, that is molecular docking. The research was conducted at Data Processing Laboratory of Department of Biology Faculty of Science and Technology, State Islamic University of Sunan Gunung Djati Bandung in December 2017 until February 2018. The result of analysis showed that daidzein compounds have excellent potential as SERMs. This is indicated by the very low energy value of binding affinity of Deidzein (-9.4 kcal / mol) compared to17-β estradiol (-8.9 kcal / mol). The smallest of energy binding affinity value indicates a very high binding ability.